Microangiopathic hemolytic anemia historical perspective

Microangiopathic hemolytic anemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Microangiopathic hemolytic anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Microangiopathic hemolytic anemia historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Microangiopathic hemolytic anemia historical perspective
on Microangiopathic hemolytic anemia historical perspective
Microangiopathic hemolytic anemia historical perspective in the news
Blogs on Microangiopathic hemolytic anemia historical perspective
Directions to Hospitals Treating Microangiopathic hemolytic anemia
Risk calculators and risk factors for Microangiopathic hemolytic anemia historical perspective

The “microangiopathic hemolytic anemia” term was first coined by Symmers, a British physician in 1952. He described 33 patients presenting with constellation of symptoms of varying severity. The symptoms included fever, hemolytic anemia, thrombocytopenia and neurological deterioration. The neurological symptoms usually present at the latter course of the disease.